Skip to content
Menu

ALPS Medical Breakthroughs ETF SBIO

Full chart Compare
Set alert

Price alert · SBIO

All alert types
52.53 USD -0.37 (-0.71%)

Regular-session close

52.53 0.00 0.00%

Pre-market · Nov 20, 4:00 AM ET

52.25 Day range 53.85
45.65 52-week range 70.85
YTD
+2.56%
1 year
+14.00%

ALPS Medical Breakthroughs ETF

Issuer
ALPS Funds
Asset class
Equity
Expense ratio
0.50%
Assets under management
$180.57M
NAV
53.90
Holdings
103
Inception
2014-12-30
Top 10 weight
32.74%

Top holdings

  1. CGON CG oncology Inc. 4.76%
  2. ORKA Oruka Therapeutics Inc. 4.35%
  3. MANE VeraDermics Inc. 3.58%
  4. DNTH Dianthus Therapeutics Inc. 3.32%
  5. TVTX Travere Therapeutics Inc. 3.28%
  6. EWTX Edgewise Therapeutics Inc. 3.11%
  7. DFTX Definium Therapeutics Inc. 2.69%
  8. SLS SELLAS Life Sciences Group Inc. 2.64%
  9. XENE Xenon Pharmaceuticals Inc. 2.56%
  10. RLAY Relay Therapeutics Inc. 2.46%
  11. AMLX Amylyx Pharmaceuticals Inc. 2.36%
  12. TARS Tarsus Pharmaceuticals Inc. 2.34%
  13. VRDN Viridian Therapeutics Inc. 2.32%
  14. ACAD ACADIA Pharmaceuticals Inc. 2.15%
  15. DYN Dyne Therapeutics Inc. 2.04%
  16. VCEL Vericel Corp. 2.02%
  17. IRON Disc Medicine Inc. 2.00%
  18. DNLI Denali Therapeutics Inc. 1.96%
  19. ZLAB Zai Lab Ltd. 1.80%
  20. IDYA Ideaya Biosciences Inc. 1.80%
  21. XNCR Xencor Inc. 1.75%
  22. MBX MBX Biosciences Inc. 1.74%
  23. NAMS Newamsterdam Pharma Co. NV 1.58%
  24. LKFT Lakefront Biotherapeutics NV 1.56%
  25. CLDX Celldex Therapeutics Inc. 1.50%

Sector weights

  1. Healthcare 100.00%

Country weights

  1. United States 91.93%
  2. Canada 2.58%
  3. China 1.88%
  4. Netherlands 1.58%
  5. United Kingdom 1.51%
  6. Switzerland 0.31%
  7. Belgium 0.20%

Updated 2026-11-18